A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT05160168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped The Sponsor terminated the study due to early dose-limiting toxicities.

Conditions

Gastrointestinal Stromal Tumors (GIST)
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasm
Digestive System Disease
Gastrointestinal Diseases

Interventions

DRUG: THE-630

Sponsor

Theseus Pharmaceuticals